So-Young Reports Strong Q1 Revenue Growth, Aesthetic Services Exceed Guidance, Projects Robust Q2
SY has more than doubled off its 52-week low of $0.82 on elevated volume (1.9× avg).
Summary
So-Young International announced strong first quarter 2026 financial results, with total revenues up 45.6% and aesthetic treatment services revenues surging 185.8%, exceeding guidance. The company also provided robust guidance for Q2 2026 aesthetic treatment services revenue.
Key Events · Earnings and Guidance · SY
-
Q1 2026 Revenue Growth
Total revenues increased by 45.6% to RMB432.8 million (US$62.7 million) compared to RMB297.3 million in Q1 2025.
-
Aesthetic Treatment Services Outperformance
Aesthetic treatment services revenues surged 185.8% to RMB282.4 million (US$40.9 million), exceeding the high end of guidance.
-
Widening Net Loss
Net loss attributable to So-Young International Inc. widened to RMB49.2 million (US$7.1 million) from RMB33.1 million in the prior year period.
-
Strong Operational Expansion
Verified treatment visits increased to approximately 148,000 from 54,400, and active users grew to over 213,000 from 75,700 year-over-year.
Analysis · SY · Technology
So-Young International reported significant revenue growth in its core aesthetic treatment services, exceeding the high end of its guidance. This strong top-line performance and robust operational expansion, including a substantial increase in active users and treatment visits, indicate strong business momentum. While the company's net loss widened, the market often prioritizes rapid growth and operational scale in this sector, especially with positive forward guidance.
At the time of this filing, SY was trading at $2.33 on NASDAQ in the Technology sector, with a market capitalization of approximately $267.6M. The 52-week trading range was $0.82 to $6.28. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.